4.8 Article

IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biochemistry & Molecular Biology

Hallmarks of Cancer: The Next Generation

Douglas Hanahan et al.

Article Immunology

MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy

James Finke et al.

INTERNATIONAL IMMUNOPHARMACOLOGY (2011)

Article Medicine, Research & Experimental

Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice

Tangying Lu et al.

JOURNAL OF CLINICAL INVESTIGATION (2011)

Article Biotechnology & Applied Microbiology

Improving Adoptive T Cell Therapy by Targeting and Controlling IL-12 Expression to the Tumor Environment

Ling Zhang et al.

MOLECULAR THERAPY (2011)

Review Immunology

Adoptive T cell therapy of cancer

Malcolm K. Brenner et al.

CURRENT OPINION IN IMMUNOLOGY (2010)

Review Immunology

Macrophages, innate immunity and cancer: balance, tolerance, and diversity

Alberto Mantovani et al.

CURRENT OPINION IN IMMUNOLOGY (2010)

Review Immunology

Myeloid-derived suppressor cell heterogeneity and subset definition

Elisa Peranzoni et al.

CURRENT OPINION IN IMMUNOLOGY (2010)

Article Multidisciplinary Sciences

Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes

Marcin Kowanetz et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Article Oncology

T-Cell Engineering for Cancer Immunotherapy

Michel Sadelain

CANCER JOURNAL (2009)

Review Immunology

Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer

Suzanne Ostrand-Rosenberg et al.

JOURNAL OF IMMUNOLOGY (2009)

Review Immunology

Myeloid-derived suppressor cells as regulators of the immune system

Dmitry I. Gabrilovich et al.

NATURE REVIEWS IMMUNOLOGY (2009)

Review Immunology

Engineering lymphocyte subsets: tools, trials and tribulations

Carl H. June et al.

NATURE REVIEWS IMMUNOLOGY (2009)

Article Medicine, Research & Experimental

IFN-γ- and TNF-dependent bystander eradication of antigen-loss variants in established mouse cancers

Bin Zhang et al.

JOURNAL OF CLINICAL INVESTIGATION (2008)

Review Biotechnology & Applied Microbiology

Immunotherapy of cancer by IL-12-based cytokine combinations

Jonathan M. Weiss et al.

EXPERT OPINION ON BIOLOGICAL THERAPY (2007)

Article Immunology

Induced sensitization of tumor stroma leads to eradication of established cancer by T cells

Bin Zhang et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2007)

Letter Oncology

The terminology issue for myeloid-derived suppressor cells

Dmitry I. Gabrilovich et al.

CANCER RESEARCH (2007)

Article Multidisciplinary Sciences

Cancer regression in patients after transfer of genetically engineered lymphocytes

Richard A. Morgan et al.

SCIENCE (2006)

Review Immunology

Immune resistance orchestrated by the tumor microenvironment

Thomas F. Gajewski et al.

IMMUNOLOGICAL REVIEWS (2006)

Review Cell Biology

Interleukin-10 and the immune response against cancer: a counterpoint

S Mocellin et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2005)

Article Biochemistry & Molecular Biology

Bystander elimination of antigen loss variants in established tumors

MT Spiotto et al.

NATURE MEDICINE (2004)

Review Immunology

Interleukin-12 and the regulation of innate resistance and adaptive immunity

G Trinchieri

NATURE REVIEWS IMMUNOLOGY (2003)

Review Multidisciplinary Sciences

Inflammation and cancer

LM Coussens et al.

NATURE (2002)

Review Biochemistry & Molecular Biology

Interleukin-12 in anti-tumor immunity and immunotherapy

MP Colombo et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2002)